📰 Operations Information News
Operations Information News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Operations Information. Real-time updates on events, politics, business and more.
December 6, 2023
Brown-Forman Corporation reported financial results for its second quarter and first half of fiscal 2024 ended October 31, 2023. Second quarter reported net sales increased 1%1 to $1.1 billion ...
August 30, 2023
Brown-Forman Corporation reported financial results for its first quarter of fiscal 2024 ended July 31, 2023, with reported net sales increasing 3%1 to $1.0 billion . In the quarter, reported...
June 7, 2023
Brown-Forman Corporation reported financial results for its fourth quarter and fiscal year ended April 30, 2023. For the fourth quarter, reported net sales increased 5%1 to $1.0 billion . In the... | June 7, 2023
May 1, 2023
01.05.2023 - First quarter 2023 BRIUMVI net sales of $7.8 million Over 400 BRIUMVI prescriptions in the first partial quarter from 165+ healthcare providers at 125+ centers Payor coverage in place for over 50% of covered lives for BRIUMVI Conference call to ...
August 31, 2022
31.08.2022 - Brown-Forman Corporation (NYSE: BFA, BFB) reported financial results for its first quarter of fiscal 2023 with reported net sales1 increasing 11% to $1.0 billion (+17% on an organic basis2) compared to the same prior-year period. In the quarter, ...
August 9, 2022
09.08.2022 - Company to host conference call today at 8:00 AM Eastern NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) - Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of ...
June 8, 2022
08.06.2022 - Brown-Forman Corporation (NYSE: BFA, BFB) reported financial results for its fourth quarter and fiscal year ended April 30, 2022. For the fourth quarter, the company’s reported net sales1 of $996 million increased 23% (+27% on an organic basis2). In ...
May 2, 2022
Company to host conference call today at 8:00 AM EasternNEW YORK, May 2, 2022 /PRNewswire/ -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharm...
March 3, 2022
LOUISVILLE, Ky.--(BUSINESS WIRE)--Mar 3, 2022--
November 6, 2021
Unless the context otherwise indicates, all references in this Management's Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, to the "Company," "we," "us," "our" or "ours" or similar words are to GWG Holdings Inc. and its direct and indirect wholly-owned and consolidated subsidiaries, references to " GWG Holdings" refer to GWG Holdings Inc.,...